Summit Therapeutics (SMMT) appoints Robert LaCaze as CCO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Summit Therapeutics (SMMT) appoints Robert LaCaze as CCO

Robert LaCaze, Innovative Growth-Driver in Oncology, Joins Summit Therapeutics as Chief Commercial Officer

March 17, 2025 4:24 PM EDT

Mr. LaCaze Brings Over 35 Years of Executive Leadership Experience in the Biopharmaceutical Industry

MIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that Robert LaCaze has joined Summit Therapeutics as Chief Commercial Officer, reporting to Manmeet S. Soni, Chief Operating Officer and Chief Financial Officer, effective immediately.

Robert W. Duggan and Dr. Maky Zanganeh, Co-CEOs of Summit Therapeutics, stated, Roberts extensive experience and proven track record in the oncology space make him an exceptional addition to our team. His leadership will be... More